ArticleJournal of inflammation (London, England)2020

NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway.

Biao Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.